Indivior PLC
INDV
View Detailed Chart
36.160USD
-0.190-0.52%
Close 12/24, 16:00（ET）Quotes delayed by 15 min
4.52BMarket Cap
36.76P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.52%
5 Days
+1.74%
1 Month
+9.24%
6 Months
+163.36%
Year to Date
+190.91%
1 Year
+201.58%
View Detailed Chart
TradingKey Stock Score of Indivior PLC
Currency: USD Updated: 2025-12-24Key Insights
Indivior PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 22/158 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 37.86.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Indivior PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Buy
Current Rating
37.857
Target Price
+3.43%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Indivior PLC Highlights
StrengthsRisks
Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 31.85% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 36.76, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 118.02M shares, increasing 2.08% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 3.44M shares of this stock.
Indivior PLC News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Indivior PLC Info
Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
Ticker SymbolINDV
CompanyIndivior PLC
CEOCiaffoni (Joseph J)
Websitehttps://www.indivior.com/en
FAQs
What is the current price of Indivior PLC (INDV)?
The current price of Indivior PLC (INDV) is 36.160.
What is the symbol of Indivior PLC?
The ticker symbol of Indivior PLC is INDV.
What is the 52-week high of Indivior PLC?
The 52-week high of Indivior PLC is 38.000.
What is the 52-week low of Indivior PLC?
The 52-week low of Indivior PLC is 7.620.
What is the market capitalization of Indivior PLC?
The market capitalization of Indivior PLC is 4.52B.
What is the net income of Indivior PLC?
The net income of Indivior PLC is 2.00M.
Is Indivior PLC (INDV) currently rated as Buy, Hold, or Sell?
According to analysts, Indivior PLC (INDV) has an overall rating of Buy, with a price target of 37.857.
What is the Earnings Per Share (EPS TTM) of Indivior PLC (INDV)?
The Earnings Per Share (EPS TTM) of Indivior PLC (INDV) is 0.984.
Related Instruments
+0.41%
+0.94%
+0.51%
+0.34%
-0.17%
+1.42%
+0.75%
+1.80%
+0.38%
+0.66%
+0.08%
+0.82%
+0.81%
+0.08%
+0.23%
-0.05%
-0.19%
0.00%
+1.54%
+0.50%Popular Symbols
